Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Browsing or searching user interfaces and other aspects
Lubricating oil with enhanced protection against wear and corrosion
Method and system for modifying satellite radio program subscriptions in a mobile vehicle
Dual-leadframe multi-chip package and method of manufacture
System and method for operating an electric power converter
Time sharing type autostereoscopic display apparatus and method for driving the same
Operation controlling apparatus
  Randomly Featured Patents
Method and system for modifying requests for remote resources
Method of fitting a metal closure
DC/DC converter
Gas-discharge display device
Droopy bowtie radiator with integrated balun
Automatic accompaniment instrument for automatically performing an accompaniment that is based on a chord progression formed by a sequence of chords
Semiconductor laser diode multi-chip module
Active photosensitive structure with buried depletion layer
Method of packaging air- and/or moisture-sensitive materials and for introducing the packaged materials into a reactor
Biomarkers for wound healing